Trust our science-backed approach.
THC is removed to below 10 PPM (effectively, no THC)
We are Opticann, Inc.®
Our management team has more than five decades of experience in clinical medicine and human health. Founded by former MedReleaf and Cynapsus Therapeutics executives, and acquired by Heritage Cannabis (Canada) in August 2020, Opticann creates innovative, world-class pharmaceutical CBD products. We develop clinically-tested CBD products that combine hemp oil extract in technologically-advanced formulations to deliver real results, fast. For you, that means relief, reliability and safety.
WE ARE OPTIMIZING CANNABINOIDS. Powered by the vision of physicians, pharmacists, researchers and natural product industry leaders, we are optimizing the most effective cannabinoid products on the market.
Our mission is to provide safe and effective medical cannabis products that you can trust, based on innovative pharmaceutical technology, and backed by scientific evidence. We pay careful attention to the quality of our manufacturing processes and product quality to carry out our purpose.
ArthroCBD are CBD softgel capsules with an innovative formulation of 25 mg CBD, 6 mg of Beta-Caryophyllene, and VESIsorb®, that has 4x higher absorption of other oral hemp products as proven by a published human clinical trial. ArthroCBD is backed by extensive safety testing and actual human clinical data.
ArthroCBD: All the relief, with NO THC | Limits unwanted side-effects
CB4 Relief™ is a new line of hemp-based products that provide reliable and superior performance, without THC, providing safer relief and limiting unwanted adverse effects on the body.
With VESIsorb®, our innovative hemp formulation has 4x the absorption of other options. We deliver ingredients in effective levels for maximum, fast and lasting effect.
Our products are rigorously tested under GMP (Good Manufacturing Products) conditions, scientifically validated, and backed by data.
CB4 Relief: Proven relief, proven safe